EFFICACY OF LOW MCHC AS A PREDICTOR FOR ALL CAUSE AND CARDIOVASCULAR DEATH IN THE PATIENTS WITH END-STAGE RENAL DISEASE: PROPENSITY SCORE MATCHED COHORT STUDY

被引：0
|
作者：
Omae, Kiyotsugu [2 ]
Ogawa, Tetsuya [1 ]
机构：
[1] Tokyo Womens Med Univ, Med Ctr East, Internal Med, Tokyo, Japan
[2] Yoshikawa Clin, Dialysis Unit, Tokyo, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP363
引用
收藏
页码：467 / 468
页数：2
相关论文
共 50 条
  • [41] Cardiovascular risk in diabetic end-stage renal disease patients
    Wang, Angela Yee-Moon
    JOURNAL OF DIABETES, 2011, 3 (02) : 119 - 131
  • [42] Sugammadex use in patients with end-stage renal disease: a historical cohort study
    Paredes, Stephania
    Porter, Steven B.
    Porter, Ivan E., II
    Ross Renew, J.
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2020, 67 (12): : 1789 - 1797
  • [43] Lower rates of endoscopy and higher mortality in end-stage renal disease patients with gastrointestinal bleeding: A propensity matched national study
    Garg, Rajat
    Parikh, Malav P.
    Chadalvada, Pravallika
    Singh, Amandeep
    Sanaka, Krishna
    Ahuja, Keerat R.
    Aggarwal, Manik
    Veluvolu, Rajesh
    Vignesh, Shivakumar
    Rustagi, Tarun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (03) : 584 - 591
  • [44] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [45] Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study
    Ferreira, Joao Pedro
    Couchoud, Cecile
    Gregson, John
    Tiple, Aurelien
    Glowacki, Francois
    London, Gerard
    Agarwal, Rajiv
    Rossignol, Patrick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (07) : 1216 - 1222
  • [46] The Efficacy of Renal Sympathetic Denervation in End-Stage Renal Disease Patients
    Kim, Chan Joon
    Chang, Kiyuk
    Kim, Daewon
    Park, Man Won
    Her, Sung-Ho
    CIRCULATION, 2018, 138
  • [47] Nocturnal Dysregulation of Heart Rate is Associated with Cardiovascular and All-cause Mortality in End-stage Renal Disease Patients on Hemodialysis
    Tanaka, Miho
    Ishii, Hideki
    Kawashima, Kazuhiro
    Kawamura, Yoshihiro
    Kamoi, Daisuke
    Furuhashi, Kyuichi
    Kumada, Yoshitaka
    Takahashi, Hiroshi
    Aoyama, Toru
    Murohara, Toyoaki
    CIRCULATION, 2010, 122 (21)
  • [48] Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study
    Benedetto, F. A.
    Rao, C. M.
    Aguglia, D. O.
    Benedetto, D.
    Imbesi, C.
    Marvelli, A.
    Tripepi, G.
    Tripepi, R.
    Basile, F.
    Zoccali, C.
    EUROPEAN HEART JOURNAL, 2010, 31 : 806 - 806
  • [49] Cardiovascular death and progression to end-stage renal disease after major surgery in elderly patients
    Lysak, N.
    Hashemighouchani, H.
    Davoudi, A.
    Pourafshar, N.
    Loftus, T. J.
    Ruppert, M.
    Efron, P. A.
    Rashidi, P.
    Bihorac, A.
    Ozrazgat-Baslanti, T.
    BJS OPEN, 2020, 4 (01): : 145 - 156
  • [50] Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: A prospective cohort study
    Tripepi, Giovanni
    Benedetto, Francesco Antonio
    Mallamaci, Francesca
    Tripepi, Rocco
    Malatino, Lorenzo
    Zoccali, Carmine
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (04): : 1316 - 1322
12345